Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Miss Amber Geer

Clinical Trials Data Manager

United Kingdom

Jump to: Affiliations Publications

Affiliations
Department of Medical Statistics
Faculty of Epidemiology and Population Health

Selected Publications
Maternal anaemia and the risk of postpartum haemorrhage: a cohort analysis of data from the WOMAN-2 trial.
WOMAN-2 trial collaborators. Electronic address: w,; WOMAN-2 trial collaborators,;
2023
The Lancet Global Health
Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births.
SHAKUR-STILL, H; ROBERTS, I; Grassin-Delyle, S; Chaudhri, R; GEER, A; ARRIBAS, M; Lamy, E; MANSUKHANI, R; Lubeya, MK; Javaid, K; Kayani, A; Israr, N; Mazhar, SB; Urien, S; Bouazza, N; Foissac, F; Prowse, D; Carrington, L; Barrow, C; ONANDIA, JG; BALOGUN, E;
2023
BJOG : an international journal of obstetrics and gynaecology
WOMAN-PharmacoTXA trial: Study protocol for a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous and oral administration of tranexamic acid in women giving birth by caesarean section.
ARRIBAS, M; ROBERTS, I; Chaudhri, R; GEER, A; Prowse, D; Lubeya, MK; Kayani, A; Javaid, K; Grassin-Delyle, S; SHAKUR-STILL, H;
2021
Wellcome open research
Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
ROBERTS, I; SHAKUR-STILL, H; Aeron-Thomas, A; BEAUMONT, D; Belli, A; BRENNER, A; Cargill, M; Chaudhri, R; Douglas, N; Frimley, L; Gilliam, C; GEER, A; JAMAL, Z; Jooma, R; MANSUKHANI, R; MINERS, A; Pott, J; Prowse, D; Shokunbi, T; WILLIAMS, J;
2021
Health technology assessment (Winchester, England)
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
BRENNER, A; Belli, A; Chaudhri, R; Coats, T; Frimley, L; Jamaluddin, SF; Jooma, R; MANSUKHANI, R; Sandercock, P; SHAKUR-STILL, H; Shokunbi, T; ROBERTS, I; CRASH-3 trial collaborators,;
2020
CRITICAL CARE
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
HALT-IT Trial Collaborators,;
2020
Lancet (London, England)
PharmacoTXA Trial: Pharmacokinetics of Tranexamic Acid after oral, intramuscular or intravenous administration: a prospective, randomised, cross-over trial in healthy volunteers
GEER, A; Prowse, D;
2020
London School of Hygiene & Tropical Medicine
Effect of tranexamic acid by baseline risk of death in acute bleeding patients: a meta-analysis of individual patient-level data from 28 333 patients.
AGERON, F-X; Gayet-Ageron, A; Ker, K; Coats, TJ; SHAKUR-STILL, H; Roberts, I; Antifibrinolytics Trials Collaboration,;
2020
BRITISH JOURNAL OF ANAESTHESIA
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
CRASH-3 trial collaborators,;
2019
LANCET
Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
Gayet-Ageron, A; PRIETO-MERINO, D; Ker, K; SHAKUR, H; AGERON, F-X; ROBERTS, I; Antifibrinolytic Trials Collaboration,;
2017
Lancet
See more information
Amber Geer

Contact

United Kingdom